Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Emory University
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Northwestern University
UNC Lineberger Comprehensive Cancer Center
University of Washington
Asan Medical Center
M.D. Anderson Cancer Center
Northwestern University
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Boston University